Immage Biotherapeutics

    OverviewSuggest Edit

    Immage Biotherapeutics Corp. is a biotechnology company, develops novel immunotherapy biologics to treat various cancers in the United States. It focuses on the development, marketing, and licensing of its patented immunotherapy candidate IMT-001, a hybrid/fusion protein vaccine that targets various tumors that express melanoma-associated antigen-A gene, including breast, liver, pancreas, prostate, melanoma, and lung diseases.
    TypePublic
    Founded2015
    HQBethesda, US
    Websiteimmagebio.com

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Feb 2019)3(+50%)
    Share Price (Dec 2019)$0

    Immage Biotherapeutics Office Locations

    Immage Biotherapeutics has an office in Bethesda
    Bethesda, US (HQ)
    10411 Motor City Dr #750
    Show all (1)

    Immage Biotherapeutics Financials and Metrics

    Immage Biotherapeutics Revenue

    USD

    Net income (Q2, 2017)

    (44.1k)

    Cash (28-Feb-2017)

    53.7k
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    General and administrative expense

    3.1k11.0k98.9k

    R&D expense

    62.2k

    Operating expense total

    3.1k11.0k161.1k

    EBIT

    (18.6k)
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

    General and administrative expense

    1.1k2.2k839.0685.02.0k1.5k4.3k19.8k27.3k26.0k28.0k24.4k

    R&D expense

    34.7k9.7k1.6m5.7k

    Operating expense total

    1.1k2.2k839.0685.02.0k1.5k4.3k19.8k62.0k35.7k1.7m30.1k

    EBIT

    (4.1k)(9.7k)(4.5k)
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Cash

    7.2k2.3k32.7k196.7k

    Accounts Receivable

    269.2m

    Prepaid Expenses

    904.0

    Current Assets

    33.6k205.0k
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

    Cash

    5.7k833.04.2k802.023.023.075.0k383.6k327.8k265.5k127.1k53.7k

    Prepaid Expenses

    5.8k3.3k

    Current Assets

    75.0k383.6k327.8k265.5k133.0k57.0k

    PP&E

    38.3k36.3k34.2k30.1k28.1k
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (12.0k)(18.6k)(53.9k)(216.5k)

    Depreciation and Amortization

    764.08.5k

    Accounts Payable

    150.01.7k(444.0)

    Cash From Operating Activities

    (11.9k)(52.4k)(215.8k)
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

    Net Income

    (9.0k)(10.6k)(13.3k)(17.4k)(9.7k)(14.2k)(36.7k)(34.0k)(103.6k)(154.5k)(1.7m)(1.7m)

    Depreciation and Amortization

    2.3k4.6k6.9k2.1k4.3k

    Accounts Payable

    860.01.8k1.8k2.0k7.4k11.9k7.1k4.4k13.3k(413.0)45.1k12.7k

    Cash From Operating Activities

    (8.2k)(8.8k)(11.5k)(15.4k)(2.3k)(2.3k)(29.5k)(25.6k)(84.8k)(147.0k)(71.1k)(143.0k)
    USDY, 2017

    Financial Leverage

    4.1 x
    Show all financial metrics

    Immage Biotherapeutics Online and Social Media Presence

    Embed Graph

    Immage Biotherapeutics Blogs

    Immage Biotherapeutics Frequently Asked Questions

    • When was Immage Biotherapeutics founded?

      Immage Biotherapeutics was founded in 2015.

    • How many employees does Immage Biotherapeutics have?

      Immage Biotherapeutics has 3 employees.

    • Who are Immage Biotherapeutics competitors?

      Competitors of Immage Biotherapeutics include Edgewise Therapeutics, Codiak Biosciences and PamBio.

    • Where is Immage Biotherapeutics headquarters?

      Immage Biotherapeutics headquarters is located at 10411 Motor City Dr #750, Bethesda.

    • Where are Immage Biotherapeutics offices?

      Immage Biotherapeutics has an office in Bethesda.

    • How many offices does Immage Biotherapeutics have?

      Immage Biotherapeutics has 1 office.